A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders - Takeaways - MDSpire

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

  • By

  • Louisa Leone

  • Tighe J. Kiernan

  • Satoshi Kuwabara

  • Michael Barnett

  • Emma Devenney

  • Rebekah M. Ahmed

  • Cindy Shin-Yi Lin

  • June 18, 2026

  • 0 min

Share

  • 1

    Diabetes mellitus (DM) is a growing global health challenge, projected to affect 853 million adults by 2050.

  • 2

    DM is increasingly recognized as a modifier of risk and prognosis across various neurological disorders.

  • 3

    The interplay between DM and neurological diseases involves complex mechanisms including inflammation and metabolic dysfunction.

  • 4

    Diabetes has been linked to increased risk of Alzheimer's disease, Parkinson's disease, and inflammatory neuropathies.

  • 5

    Understanding the relationship between DM and neurological conditions may inform prevention strategies and therapeutic interventions.

Original Source(s)

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

  • by Louisa Leone, Tighe J. Kiernan, Satoshi Kuwabara, Michael Barnett, Emma Devenney, Rebekah M. Ahmed, Cindy Shin-Yi Lin

  • June 18, 2026

Related Content

Editorial: Immune functions of neuroglia

HLA-DRB1*15:01 drives sex- and age-dependent microglial immune phenotypes and neuroimmune signaling

Correction: The association between systemic lupus erythematosus and cognitive impairment or dementia: a meta-analysis